Exchange: NYSEArca·Updated 02:06 AM EDT

VOO News

News
all
press releases
Investment Advisor Ross Gerber Calls Micron Decline Overdone — Cites Multi-Year Supply Agreements
Micron has supply contracts for years out, Gerber said, dismissing concerns of Chinese competition.
Stocktwits
Investment Advisor Ross Gerber Calls Micron Decline Overdone — Cites Multi-Year Supply Agreements
Micron has supply contracts for years out, Gerber said, dismissing concerns of Chinese competition.
Stocktwits
More News
If I Could Invest $1,000 in Just 1 Dividend Stock for the Next 5 Years, I'd Pick This Clear Standout Over the Vanguard S&P 500 ETF (VOO)
Key PointsThe S&P 500 index's dividend yield has fallen to about 1...
Nasdaq News: Markets
S&P 500, Nasdaq 100 End Lower On Chipmaker Weakness, While Salesforce Gains Aid Dow — META, MSFT, BMBL, CRM, SNAP In Focus
Wall Street’s biggest banks, including JPMorgan, Morgan Stanley, and Wells Fargo, will report earnings this week.
Stocktwits
Afraid of a Stock Market Crash? 4 Great ETFs to Buy Regardless.
Key PointsThe Vanguard S&P 500 ETF is a great core holding...
Nasdaq News: Markets
4 Vanguard Funds Worth Buying and Holding for the Next 20 Years
Key PointsCore holdings like the Vanguard S&P 500 ETF (VOO) and the Vanguard Total Stock Market ETF (VTI) always make great long-term investments...
Nasdaq News: Markets
Vanguard's S&P 500 Index Fund Charges About $3 a Year on $10,000. The Average Stock Fund Charges About $40.
Key PointsThe Vanguard S&P 500 ETF charges 0.03% a year, or about $3 for a $10,000 investment...
Nasdaq News: Markets
Prediction: This Is What a $5,000 Investment in the Vanguard S&P 500 ETF (VOO) Will Be Worth by 2040
Key PointsThe S&P 500 has averaged annual gains of close to 10% over many decades...
Nasdaq News: Markets
S&P 500, Nasdaq 100, Dow End Week Higher With Traders Eyeing Earnings Season — MSFT, NFLX, SPCX, ASTS In Focus
Wall Street’s biggest banks, including JPMorgan, Morgan Stanley, and Wells Fargo, will report earnings next week.
Stocktwits
MRNA Stock Sets New 52-Week High As Nasdaq-100 Reentry Meets NIH Cancer-Vaccine Push
Moderna shares on Friday were driven by multiple catalysts, including a Nasdaq-100 entry, a New York Times report on a planned NIH-backed cancer-vaccine push and a price target hike.
Stocktwits
I've Owned the Vanguard S&P 500 ETF for 6 Years. Here's Why I'm Not Selling.
Key PointsThe Vanguard S&P 500 ETF tracks the S&P 500...
Nasdaq News: Markets

Advertisement|Remove ads.